Previous close | 385.73 |
Open | 384.48 |
Bid | 370.12 x 800 |
Ask | 0.00 x 800 |
Day's range | 364.89 - 390.33 |
52-week range | 310.42 - 415.73 |
Volume | |
Avg. volume | 544,422 |
Market cap | 26.953B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 48.57 |
EPS (TTM) | 7.58 |
Earnings date | 25 July 2024 - 29 July 2024 |
Forward dividend & yield | 0.80 (0.22%) |
Ex-dividend date | 31 July 2024 |
1y target est | 400.43 |
Despite a dip in Q1 performance, West Pharmaceutical projects a robust year with strategic expansions and improved guidance.
West Pharmaceutical's (WST) first-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.
Company Reaffirms Full-Year Guidance and Raises EPS Outlook